Paolo Tarantino shared a previous post of him on X and added:

“3 more years, same feeling: so grateful for all the inspiration, motivation, collaborations and friendships I found on this platform!”

Quoting the previous post:

“3 years ago I was joining Twitter, unsure of what I was gonna find

3 years later I find myself involved in this invaluable network of minds, connections, ideas & positivity

Thanks to all the people in this picture & outside of it for making of Med Twitter a very special place!”

Source: Paolo Tarantino/X

Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.